OCULAR THERAPEUTIX INC

For the period ended Dec 31, 2023. Filed Mar 11, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 11, 2024

OCUL$6.85+3.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands, except share and per share data)


· · December 31, · · December 31,
· 2023 · 2022
Assets · ·
Current assets: · · ·
Cash and cash equivalents	$195,807	$102,300
Accounts receivable, net	26,179	21,325
Inventory	2,305	1,974
Restricted cash	150	—
Prepaid expenses and other current assets	7,794	4,028
Total current assets	232,235	129,627
Property and equipment, net	11,739	9,856
Restricted cash	1,614	1,764
Operating lease assets	6,472	8,042
Total assets	$252,060	$149,289
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$4,389	$5,123
Accrued expenses and other current liabilities	28,666	24,097
Deferred revenue	255	576
Operating lease liabilities	1,586	1,599
Total current liabilities	34,896	31,395
Other liabilities:
Operating lease liabilities, net of current portion	6,878	8,678
Derivative liabilities	29,987	6,351
Deferred revenue, net of current portion	14,135	13,387
Notes payable, net	65,787	25,257
Other non-current liabilities	108	93
Convertible Notes, net	9,138	28,749
Total liabilities	160,929	113,910
Commitments and contingencies (Note 17)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at December 31, 2023 and December 31, 2022, respectively	—	—
Common stock, $0.0001 par value; 200,000,000 shares authorized and 114,963,193 and 77,201,819 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively	12	8
Additional paid-in capital	788,697	652,213
Accumulated deficit	(697,578)	(616,842)
Total stockholders’ equity	91,131	35,379
Total liabilities and stockholders’ equity	$252,060	$149,289

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.